Special thanks to our BioSymposium event sponsors

BioMelbourne Network

Web: biomelbourne.org
Email: [email protected]
Phone: +61 3 9667 8181
LinkedIn: linkedin.com/company/biomelbourne-network/
Twitter: twitter.com/biomelb

BioMelbourne Network is the peak body in the Victorian healthtech industry, driving engagement and growth through local and international networks. Since 2001, we are actively fostering and growing an innovative, globally competitive sector and transforming our Network as well as the broader Victorian ecosystem.

Our members are diverse and experts in their respective fields, from early-career researchers to company executives and experienced directors, and start-ups through to large multinational corporations. We represent universities, researchers, manufacturers, government departments and the services sector, which includes commercialisation, product design and development, intellectual property, investment and legal sectors.

We are committed to maximising our value to the ecosystem through the delivery of our three-year strategic plan.

State Government of Victoria

Web:  djsir.vic.gov.au/health-tech
Email: [email protected]
Twitter: https://twitter.com/@VicGov_DJSIR

About Us:

Victoria is home to world-class health technology companies and is a preferred location for many global leaders including CSL, Moderna, BioNTech, Illumina, Telix Pharmaceuticals and Pfizer. International companies partner with Victoria for its outstanding strengths in commercial product development, its cost-competitive environment for basic discovery, clinical and commercial research, and its strong collaborative networks and supportive government.

Victoria is a global leader in health technologies research and manufacturing, delivering a sector value add of $5.5 billion in 2022. Victoria’s research and development capabilities include:

Victoria is a global leader in health technologies research and manufacturing, delivering a sector value add of $5.5 billion in 2022. Victoria’s research and development capabilities include: infectious disease and diagnostics; digital health and patient monitoring; cancer; cell therapies and regenerative medicine; neuroscience; paediatrics.

Victoria’s health technologies ecosystem is supported by its skilled and multicultural talent pool, favourable regulatory and research and development environment, and world leading infrastructure - all backed by the Victorian Government’s long-term investment into the sector.

The Victorian Government has recognised health technologies as a priority industry sector for more than two decades and is committed to working with business to grow the research and innovation ecosystem. The Victorian Government has a global network of 23 international business offices, actively working with companies worldwide to assist them to partner with Victoria to develop novel health technologies and services.

We look forward to connecting with you.

For more information on how the Victorian Government can support your business, please visit our website. 

CSIRO

Web: www.csiro.au 
Phone: 1300 363 400 
 
About Us:

CSIRO’s vision is to create a better future for Australia by solving the greatest challenges through innovative science and technology.
We work with biomedical companies to deliver new medical treatments and technologies that benefit millions of people in Australia and overseas, helping them live longer, healthier and more productive lives.

CSIRO is one of the largest multidisciplinary science organisations in the world with over 6000 staff working in state-of-the-art facilities across Australia. We support local businesses and the broader research community across preclinical, biomedical manufacturing, devices and sensors, diagnostics, eHealth and clinical trials.

FB Rice

Web: www.fbrice.com.au
Phone: +61 3 8618 4100
Email: [email protected] 
 
About Us:

Founded more than 70 years ago, FB Rice has become Australia’s most trusted intellectual property firm with offices across the country and a well-established presence in New Zealand and South-East Asia.
Today, it combines world-leading expertise across biotechnology, chemistry, computer and electrical sciences, engineering and medical devices with integrity and a determination to help clients achieve their goals.

Drawing on deep industry and practice experience, FB Rice’s dedicated Biotechnology Group supports clients in key areas including but not limited to adoptive cell therapy, immunology, gene therapy, drug development, biologics and biosimilars, microbiology, stem cell therapies, genetics and genomics, bioinformatics, vaccines and diagnostics, and plant biology and medical engineering.

FB Rice focuses on nurturing and growing best in class attorneys who are not only outstanding in the field of IP but also understand their clients’ environment and can tailor IP advice and strategy accordingly. Their goal is always to provide an exceptional client service to assist their clients in achieving success.

This dedication to providing clients with the highest standard of service has seen FB Rice win twelve Australian Client Choice Awards, including being named Best Specialist IP Firm six years running, Best Client Experience Firm for Specialist IP since 2021, and Most Innovative Specialist IP & Related Services Firm since 2022.

FB Rice champions innovation and creates value.

Honan

Web: www.honan.com.au 
Contact: Daniel Reid
Phone: 0400 964 740 
Email: [email protected]

About Us:

Thanks to its innovative, customer-led approach and deep sector experience, Honan adds value to clients beyond just insurance, through comprehensive risk profile assessments and clear, easy-to-understand advice.

Founded in Melbourne, Australia in 1964, we know what it takes to achieve growth and stability. From program placement to claims management and risk consulting, we understand the bespoke challenges faced by biotech, life science and pharmaceutical companies. As you manage complex regulatory requirements and unique market conditions, we will draw on our deep knowledge of your key risks to offer solutions that support your vision.

Honan advisors bring a depth of expertise and fresh thinking to deliver a high-quality, customer-led, value-added service that’s more akin to leading consultancies than the traditional world of corporate insurance. We partner with our clients for the long-term, understanding their business and market holistically to develop creative and strategic solutions that ultimately help them grow with confidence.

On 30th November 2023, Marsh completed its acquisition of the Honan Insurance Group. Marsh is the world’s leading insurance broker and risk adviser. With more than 45,000 colleagues operating in more than 130 countries, Marsh serves commercial and individual clients with data driven risk solutions and advisory services. Marsh is a business of Marsh McLennan (NYSE: MMC), the leading global professional services firm in the areas of risk, strategy, and people.

This is an exciting new chapter and a growth opportunity for Marsh and Honan, both equally focused on excellent client service, a commitment to the communities in which we work, and in developing our colleagues and expanding opportunities for them.

Monash Talent

Web: https://www.monash.edu/talent 
Contact: Lauren Howard
Email: [email protected] 
LinkedIn: https://au.linkedin.com/company/monash-talent 

About Us:

Monash Talent is the centralised talent function of Monash University, providing tailored early career talent services for industry, that reduce recruitment expenses and simplify hiring.

At Monash Talent, we are committed to helping the life sciences sector build the workforce of the future. Monash Talent removes the complexity of navigating a university ecosystem, while offering a multitude of early career solutions, including temp work, part-time and full-time placements, internships, workforce upskilling and employer branding campaigns.

As Australia's biggest university, we have unrivalled access to top student and graduate talent. Our network comprises over 86,000 students nationally and globally, and more than 400,000 alumni.

Prime Accounting and Business Advisory Pty Ltd

Web: https://www.primefinancial.com.au/services/accounting-business-advisory 
LinkedIn: https://www.linkedin.com/company/prime-financial-group-ltd 
Contact: Simone Quin
Email: [email protected] 
Contact: Brendan Brown
Email: [email protected] 

About Us:

We are a market leading Advice, Capital & Asset Management Group with 1.1B in FUM.

We believe in uncapped opportunities and are committed to creating prosperous and sustainable financial futures for all.

SeerPharma Pty Ltd

Web: www.seerpharma.com 
Contact: Biju Kishor
Email: [email protected] 

About Us:

SeerPharma is a team of consultants that provide advice, training, software solutions from MasterControl, and contract labour resources to pharmaceutical, medical device and life science companies in the Asia-Pacific region, on matters of Quality Assurance and GMP compliance. We have been serving our clients in the Asia-Pacific region for over 30 years from our offices in Australia and Singapore, and are also able to provide assistance in Europe through our affiliate in the UK.
 
Our team of consultants have extensive experience working with clients supplying or looking to enter the supply chain of a therapeutic product. We work with organisations looking to ensure that their facilities, equipment, quality systems and processes are compliant with FDA, PIC/S, TGA, WHO, ISO, ICH and other GxP regulations and standards that apply to their product(s).

Through our work we aim to “Advance Quality and GMP Best Practices in the APAC region” for the Pharmaceutical and Medical Device Industry.